CING
Cingulate Inc.NASDAQHealthcare$6.14+0.98%ClosedMarket Cap: $34.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
13.42
P/S
0.00
EV/EBITDA
-1.68
DCF Value
$0.05
FCF Yield
39194.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-515.3%
ROA
-148.9%
ROIC
-0.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-5.6M | $-6.5M | $-0.87 | — |
| FY 2025 | $0.00 | -Infinity% | $-19.9M | $-22.4M | $-4.13 | — |
| Q3 2025 | $0.00 | -Infinity% | $-6.0M | $-7.3M | $-1.35 | — |
| Q2 2025 | $0.00 | -Infinity% | $-4.6M | $-4.8M | $-1.09 | — |
| Q1 2025 | $0.00 | -Infinity% | $-3.7M | $-3.8M | $-1.04 | — |
| Q4 2024 | $0.00 | -Infinity% | $-6.2M | $-6.1M | $-1.80 | — |
| FY 2024 | $0.00 | -Infinity% | $-15.6M | $-15.5M | $-10.20 | — |
| Q3 2024 | $0.00 | -Infinity% | $-3.3M | $-4.1M | $-1.83 | — |
| Q2 2024 | $0.00 | -Infinity% | $-3.2M | $-3.2M | $0.64 | — |
| Q1 2024 | $0.00 | -Infinity% | $-2.9M | $-3.0M | $-7.21 | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.8M | $-6.9M | $-18.62 | — |
| FY 2023 | $0.00 | -Infinity% | $-22.8M | $-23.5M | $-311.99 | — |